A critical breakthrough in cancer study is arising with the use of nanobodies to reactivate damaged p53. This vital malignant suppressor protein is frequently inactivated in several types of cancer, leading https://7bookmarks.com/story21801289/mini-antibodies-revive-the-p53-protein-new-potential-approach-for-tumor-treatment